Harvard Bioscience Inc.

6.53-0.0200-0.31%Vol 183.14K1Y Perf 163.71%
Apr 9th, 2021 16:00 DELAYED
BID6.49 ASK6.75
Open6.58 Previous Close6.55
Pre-Market- After-Market6.50
 - -  -0.03 -0.46%
Target Price
8.00 
Analyst Rating
Moderate Buy 2.00
Potential %
22.51 
Finscreener Ranking
★★+     49.37
Insiders Trans % 3/6/12 mo.
-100/-100/60 
Value Ranking
★★     47.81
Insiders Value % 3/6/12 mo.
-100/-100/-15 
Growth Ranking
★★     45.85
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/26 
Income Ranking
 —    -
Market Cap260.06M 
Earnings Rating
Neutral
Price Range Ratio 52W %
87.99 
Earnings Date
4th May 2021

Today's Price Range

6.386.58

52W Range

2.067.14

5 Year PE Ratio Range

-148.00-7.00

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
20.04%
1 Month
25.10%
3 Months
54.74%
6 Months
95.51%
1 Year
163.71%
3 Years
24.38%
5 Years
140.07%
10 Years
18.73%

TickerPriceChg.Chg.%
HBIO6.53-0.0200-0.31
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
1.20
2.50
0.41
0.75
-0.50
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
56.90
-2.40
5.10
-3.60
-3.70
RevenueValueIndustryS&P 500US Markets
78.33M
1.97
-1.07
0.35
Earnings HistoryEstimateReportedSurprise %
Q04 20200.040.0650.00
Q02 2020-0.03-
Q01 20200.02-0.03-250.00
Q04 20190.070.070.00
Q03 20190.030.02-33.33
Q02 20190.020.0350.00
Q01 20190.010.00-100.00
Q04 20180.050.050.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.01-93.33Negative
6/2021 QR0.01-95.83Negative
12/2021 FY0.16--
12/2022 FY0.28--
Next Report Date4th May 2021
Estimated EPS Next Report0.01
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume183.14K
Shares Outstanding39.83M
Trades Count1.85K
Dollar Volume1.39M
Avg. Volume213.33K
Avg. Weekly Volume250.67K
Avg. Monthly Volume339.88K
Avg. Quarterly Volume219.29K

Harvard Bioscience Inc. (NASDAQ: HBIO) stock closed at 6.53 per share at the end of the most recent trading day (a -0.31% change compared to the prior day closing price) with a volume of 183.25K shares and market capitalization of 260.06M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 505 people. Harvard Bioscience Inc. CEO is James W. Green.

The one-year performance of Harvard Bioscience Inc. stock is 163.71%, while year-to-date (YTD) performance is 52.21%. HBIO stock has a five-year performance of 140.07%. Its 52-week range is between 2.06 and 7.14, which gives HBIO stock a 52-week price range ratio of 87.99%

Harvard Bioscience Inc. currently has a PE ratio of -27.30, a price-to-book (PB) ratio of 2.84, a price-to-sale (PS) ratio of 2.77, a price to cashflow ratio of 22.60, a PEG ratio of 2.32, a ROA of -4.65%, a ROC of -1.19% and a ROE of -9.43%. The company’s profit margin is -3.70%, its EBITDA margin is 5.10%, and its revenue ttm is $78.33 Million , which makes it $1.97 revenue per share.

Of the last four earnings reports from Harvard Bioscience Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.01 for the next earnings report. Harvard Bioscience Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Harvard Bioscience Inc. is Moderate Buy (2), with a target price of $8, which is +22.51% compared to the current price. The earnings rating for Harvard Bioscience Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Harvard Bioscience Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Harvard Bioscience Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 0.28, CCI20 : -0.79, Chaikin Money Flow : -0.18, MACD : -0.06, Money Flow Index : 36.83, ROC : 1.11, RSI : 52.45, STOCH (14,3) : 80.00, STOCH RSI : 1.00, UO : 49.71, Williams %R : -20.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Harvard Bioscience Inc. in the last 12-months were: Alan I. Edrick (Buy at a value of $105 000), James W. Green (Buy at a value of $50 600), James W. Green (Sold 35 000 shares of value $209 300 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

Harvard Bioscience Inc.

Harvard Bioscience Inc is a US-based developer, manufacturer and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States.

CEO: James W. Green

Telephone: +1 508 893-8999

Address: 84 October Hill Road, Holliston 01746, MA, US

Number of employees: 505

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

58%42%

Bearish Bullish

54%46%

News

Stocktwits